CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Placebo +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07265115
NCT07265115N/ACompleted
CompareCT.gov

Advanced Preventive Nutritional Supplements Targeting Pathologies in the Preclinical Phase

Centro de Edafología y Biología Aplicada del Segura·interventional·Posted Dec 4, 2025·Updated Apr 28, 2026

In Brief

A clinical study evaluating Placebo, Capsules with active ingredients, and 2 other interventions for Prediabetes. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The main objective of this intervention study was to evaluate the functionality of a multi-target preparation (rich in phloretin from apple, chromium picolinate, zinc, magnesium and cinnamon extract) on the glucose response of individuals who show factors associated with prediabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrediabetes
CountriesSpain
CollaboratorsSan Antonio Technologies - San Antonio Catholic University of Murcia

Timeline

N/ACompletedFinished
2026
First PostedDec 4, 2025
Enrollment StartJan 12, 2026
Primary CompletionFeb 10, 2026
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 7 months ago

Interventions

Placebodietary

Capsules with microcrystalline cellulose 102

Capsules with active ingredientsdietary

Capsules with phloretin rich apple extract, magnesium oxide, cinnamon extract, zinc citrate and chromium picolinate

Placebo Repetitiondietary

Repetition of the placebo (capsules with microcrystalline cellulose 102) intake

Capsules with active ingredients Repetitiondietary

Repetition of the supplement intake (Capsules with phloretin rich apple extract, magnesium oxide, cinnamon extract, zinc citrate and chromium picolinate)